Richard Parker

Richard Parker

Auto-generated profile, based on publicly available information

Richard Parker

Leeds Liver Unit St James's University Hospital Leeds UK

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in The Lancet
Verified
Journal Article
Closed access
MAMatthew James Armstrong
Matthew James Armstrong
PGPiers Gaunt
Piers Gaunt
GAGuruprasad Aithal
Guruprasad Aithal
DBDarren Barton
Darren Barton
DHDiana Hull
Diana Hull
PNPhilip Noel Newsome
Philip Noel Newsome

28 October 2019 in Global Public Health
Verified
Journal Article
Closed access
JGJonathan Garcia
Jonathan Garcia
NVNancy Vargas
Nancy Vargas
JCJesse L. Clark
Jesse L. Clark
MÁMario Magaña Álvarez
Mario Magaña Álvarez
DNDevynne A. Nelons
Devynne A. Nelons
RPRichard G. Parker
Richard G. Parker
Social isolation describes a lack of a sense of belonging, the inability to engage and connect with others, and the neglect or deterioration of social relationships. This conceptual review describes how social isolation and connectedness affect the well-being of LGBTQ youth. Most studies focused on the psychosocial experience of social isolation, which led to suicide attempt, self-harm, sexual risk, and substance use. Scholarly work has drawn from a variety of frameworks, ranging from minority stress theory to positive youth development, to devise interventions that target isolation and connectedness in schools, community-based organisations, and in online environments. Finally, we discuss the importance of addressing social, cultural, and structural dimensions of social isolation in order to foster enabling environments that allow LGBTQ youth to thrive. This conceptual review suggests that individual and social transformations are the result of young people's meaningful participation in shaping their environment, which is made possible when their capabilities are fostered through social well-being. Our findings suggest the need for measures of social isolation among youth in databanks produced by global institutions, such as the World Health Organization.

1 November 2021 in Journal of Hepatology
Verified
Journal Article
Closed access
JAJuan Pablo Arab
Juan Pablo Arab
LDLuis Antonio Díaz
Luis Antonio Díaz
NBNatalia Baeza
Natalia Baeza
FIFrancisco Idalsoaga
Francisco Idalsoaga
EFEduardo Fuentes-López
Eduardo Fuentes-López
RBRamon Bataller
Ramon Bataller

1 October 2013 in Transplantation
Verified
Journal Article
Closed access
CCChris Corbett
Chris Corbett
MAMatthew J. Armstrong
Matthew J. Armstrong
RPRichard Parker
Richard Parker
KWKerry Webb
Kerry Webb
JNJames M. Neuberger
James M. Neuberger
Depression affects up to 60% of solid-organ recipients and is independently associated with both mortality (hazard ratio for death of ~2) and de novo malignancy after transplantation, although the mechanism is not clear. Both pretransplantation psychosis and depression occurring more than 2 years after transplantation are associated with increased noncompliance and graft loss. It remains to be shown that effective treatment of depression is associated with improved outcomes and quality of life. Immunosuppressive drugs (especially corticosteroids and calcineurin inhibitors) and physiologic challenges can precipitate deterioration in mental health. All potential transplant candidates should be assessed for mental health problems and preexisting medical conditions that can mimic mental health problems, such as uremic, hepatic, or hypoxic encephalopathy, should be identified and treated appropriately. Expert mental health review of those with identified risk factors (such as previous suicide attempts, history of mental illness or noncompliance with medications) is advisable early in the transplant assessment process to mitigate risk and support the patient. Patients with mental health disorders, when adequately controlled and socially supported, have outcomes similar to the general transplant population. Therefore, exclusion from transplantation based on the diagnosis alone is neither ethically nor medically justified. However, it is ethically and clinically justifiable to deny access to transplantation to those who, despite full support, would have a quality of life that is unacceptable to the candidate or are likely to be noncompliant with treatment or follow-up, which would lead to graft loss.

1 September 2019 in Journal of Hepatology
Verified
Journal Article
Closed access
RPRichard Parker
Richard Parker
GAGuruprasad Aithal
Guruprasad Aithal
UBUlrik Becker
Ulrik Becker
DGDermot Gleeson
Dermot Gleeson
SMSteven Masson
Steven Masson
IRIan A. Rowe
Ian A. Rowe

13 March 2013 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
RPR. Parker
R. Parker
MAM. J. Armstrong
M. J. Armstrong
CCC. Corbett
C. Corbett
IRI. A. Rowe
I. A. Rowe
DHD. D. Houlihan
D. D. Houlihan